Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 17/20 | 0.69 |
| ▸ | AKR1A1 | P14550 | 14/20 | 0.69 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Imirestat SCHEMBL30924520 | 0.81 | AKR1A1 (1.00) | AKR1B1AKR1A1 | |
| Imirestat SCHEMBL49034 | 0.81 | AKR1A1 (1.00) | AKR1B1AKR1A1 | |
| SCHEMBL9810984 | 0.76 | AKR1A1 (0.88) | AKR1B1AKR1A1 | |
| Alconil SCHEMBL30661866 | 0.75 | AKR1A1 (0.85) | AKR1B1AKR1A1 | |
| Alconil SCHEMBL1201487 | 0.75 | AKR1A1 (0.85) | AKR1B1AKR1A1 | |
| SCHEMBL10606075 | 0.75 | AKR1B1 (0.65) | AKR1B1AKR1A1AKR1B10MAPT | |
| SCHEMBL9673837 | 0.74 | AKR1A1 (0.82) | AKR1B1AKR1A1 | |
| SCHEMBL10927385 | 0.74 | AKR1A1 (0.82) | AKR1B1AKR1A1 | |
| SCHEMBL20845832 | 0.74 | AKR1A1 (1.00) | AKR1B1AKR1A1 | |
| SCHEMBL10928977 | 0.74 | AKR1A1 (0.82) | AKR1B1AKR1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021061763-A1 | ALDOKETO REDUCTASE INHIBITORS AND USES THEREOF | CASE WESTERN RESERVE UNIVERSITY (US) | 2021-04-01 | — | — | WO | disclosed |
| EP-0092385-B1 | HYDANTOIN DERIVATIVES FOR USE IN INHIBITING ALDOSE REDUCTASE ACTIVITY, COMPOSITIONS THEREFOR AND PROCESS FOR PREPARING SPIRO-FLUOREN COMPOUNDS | ALCON LABORATORIES, INC. (US) | 1991-06-12 | — | — | EP | disclosed |
| US-4540700-A | Treatment of diabetic complications with certain spiro-imidazolidine-diones | ALCON LABORATORIES, INC. (US) | 1985-09-10 | — | — | US | disclosed |
| US-4436745-A | TETRACYCLIC SPIROHYDANTOINS | ALCON LABORATORIES, INC. (US) | 1984-03-13 | — | — | US | disclosed |
| WO-1983003543-A1 | METHOD OF INHIBITING ALDOSE REDUCTASE ACTIVITY, COMPOSITIONS THEREFOR AND PROCESS FOR PREPARING SPIRO-FLUOROFLUOREN AND SPIRO-DIFLUOROFLUOREN COMPOUNDS | ALCON LAB INC (US) | 1983-10-27 | — | — | WO | disclosed |
| EP-0092385-A2 | Hydantoin derivatives for use in inhibiting aldose reductase activity, compositions therefor and process for preparing spiro-fluoren compounds | ALCON LABORATORIES, INC. (US) | 1983-10-26 | — | — | EP | disclosed |